{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:00:08Z","timestamp":1775026808756,"version":"3.50.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T00:00:00Z","timestamp":1111449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/ni1178","type":"journal-article","created":{"date-parts":[[2005,3,22]],"date-time":"2005-03-22T19:19:24Z","timestamp":1111519164000},"page":"345-352","source":"Crossref","is-referenced-by-count":2042,"title":["Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self"],"prefix":"10.1038","volume":"6","author":[{"given":"Shimon","family":"Sakaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,22]]},"reference":[{"key":"BFni1178_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","volume":"18","author":"EM Shevach","year":"2000","unstructured":"Shevach, E.M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423\u2013449 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni1178_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ni0901-816","volume":"2","author":"KJ Maloy","year":"2001","unstructured":"Maloy, K.J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2, 816\u2013822 (2001).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1034\/j.1600-065X.2001.1820107.x","volume":"182","author":"A Coutinho","year":"2001","unstructured":"Coutinho, A. et al. Regulatory T cells: the physiology of autoreactivity in dominant tolerance and \u201cquality control\u201d of immune responses. Immunol. Rev. 182, 89\u201398 (2001).","journal-title":"Immunol. Rev."},{"key":"BFni1178_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531\u2013562 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni1178_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20040812","volume":"200","author":"C Baecher-Allan","year":"2004","unstructured":"Baecher-Allan, C. & Hafler, D.A. Suppressor T cells in human diseases. J. Exp. Med. 200, 273\u2013276 (2004).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"key":"BFni1178_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057\u20131061 (2003).","journal-title":"Science"},{"key":"BFni1178_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337\u2013342 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1084\/jem.161.1.72","volume":"161","author":"S Sakaguchi","year":"1985","unstructured":"Sakaguchi, S., Fukuma, K., Kuribayashi, K. & Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72\u201387 (1985).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR11","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.172.6.1701","volume":"172","author":"F Powrie","year":"1990","unstructured":"Powrie, F. & Mason, D. OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset. J. Exp. Med. 172, 1701\u20131708 (1990).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR12","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1073\/pnas.87.19.7618","volume":"87","author":"U McKeever","year":"1990","unstructured":"McKeever, U. et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc. Natl. Acad. Sci. USA 87, 7618\u20137622 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.184.2.387","volume":"184","author":"M Asano","year":"1996","unstructured":"Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387\u2013396 (1996).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR14","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.162.9.5317","volume":"162","author":"M Itoh","year":"1999","unstructured":"Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317\u20135326 (1999).","journal-title":"J. Immunol."},{"key":"BFni1178_CR15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4049\/jimmunol.160.3.1212","volume":"160","author":"E Suri-Payer","year":"1998","unstructured":"Suri-Payer, E., Amar, A.Z., Thornton, A.M. & Shevach, E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212\u20131218 (1998).","journal-title":"J. Immunol."},{"key":"BFni1178_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1034\/j.1600-065X.2001.1820115.x","volume":"182","author":"B Singh","year":"2001","unstructured":"Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190\u2013200 (2001).","journal-title":"Immunol. Rev."},{"key":"BFni1178_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ni1179","volume":"6","author":"JD Fontenot","year":"2005","unstructured":"Fontenot, J.D. & Rudensky, A. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331\u2013337 (2005).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00002281-200307000-00010","volume":"15","author":"E Gambineri","year":"2003","unstructured":"Gambineri, E., Torgerson, T.R. & Ochs, H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430\u2013435 (2003).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFni1178_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow, M.E. et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68\u201373 (2001).","journal-title":"Nat. Genet."},{"key":"BFni1178_CR20","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila, T.A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75\u2013R81 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFni1178_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18\u201320 (2001).","journal-title":"Nat. Genet."},{"key":"BFni1178_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20\u201321 (2001).","journal-title":"Nat. Genet."},{"key":"BFni1178_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2249.2002.01940.x","volume":"130","author":"A Tommasini","year":"2002","unstructured":"Tommasini, A. et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130, 127\u2013130 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"BFni1178_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-065X.1995.tb00092.x","volume":"148","author":"I Horak","year":"1995","unstructured":"Horak, I., Lohler, J., Ma, A. & Smith, K.A. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148, 35\u201344 (1995).","journal-title":"Immunol. Rev."},{"key":"BFni1178_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.182.6.1769","volume":"182","author":"S Kramer","year":"1995","unstructured":"Kramer, S., Schimpl, A. & Hunig, T. Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182, 1769\u20131776 (1995).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford, D.M. et al. Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521\u2013530 (1995).","journal-title":"Immunity"},{"key":"BFni1178_CR27","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.7770771","volume":"268","author":"H Suzuki","year":"1995","unstructured":"Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor \u03b2. Science 268, 1472\u20131476 (1995).","journal-title":"Science"},{"key":"BFni1178_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/clin.1996.0190","volume":"81","author":"G Klebb","year":"1996","unstructured":"Klebb, G. et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin. Immunol. Immunopathol. 81, 282\u2013286 (1996).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFni1178_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T","volume":"31","author":"M Wolf","year":"2001","unstructured":"Wolf, M., Schimpl, A. & Hunig, T. Control of T cell hyperactivation in IL-2-deficient mice by CD4+CD25- and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637\u20131645 (2001).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR30","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.4049\/jimmunol.169.9.4850","volume":"169","author":"AR Almeida","year":"2002","unstructured":"Almeida, A.R., Legrand, N., Papiernik, M. & Freitas, A.A. Homeostasis of peripheral CD4+ T cells: IL-2R\u03b1 and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J. Immunol. 169, 4850\u20134860 (2002).","journal-title":"J. Immunol."},{"key":"BFni1178_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1074-7613(02)00367-9","volume":"17","author":"TR Malek","year":"2002","unstructured":"Malek, T.R. et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2R\u03b2-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167\u2013178 (2002).","journal-title":"Immunity"},{"key":"BFni1178_CR32","doi-asserted-by":"publisher","first-page":"8832","DOI":"10.1073\/pnas.132254399","volume":"99","author":"M Murakami","year":"2002","unstructured":"Murakami, M. et al. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. USA 99, 8832\u20138837 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR33","unstructured":"Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press)."},{"key":"BFni1178_CR34","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1084\/jem.20020190","volume":"196","author":"GC Furtado","year":"2002","unstructured":"Furtado, G.C., Curotto de Lafaille, M.A., Kutchukhidze, N. & Lafaille, J.J. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196, 851\u2013857 (2002).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR35","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.4049\/jimmunol.172.11.6519","volume":"172","author":"AM Thornton","year":"2004","unstructured":"Thornton, A.M., Donovan, E.E., Piccirillo, C.A. & Shevach, E.M. Cutting edge: IL-2 Is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J. Immunol. 172, 6519\u20136523 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/eji.1830260131","volume":"26","author":"P Chastagner","year":"1996","unstructured":"Chastagner, P. et al. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor \u03b1, \u03b2 and \u03b3 chain expression for T cell growth. Eur. J. Immunol. 26, 201\u2013206 (1996).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(08)60386-7","volume":"70","author":"BH Nelson","year":"1998","unstructured":"Nelson, B.H. & Willerford, D.M. Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1\u201381 (1998).","journal-title":"Adv. Immunol."},{"key":"BFni1178_CR38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7520605","volume":"265","author":"Y Chen","year":"1994","unstructured":"Chen, Y. et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237\u20131240 (1994).","journal-title":"Science"},{"key":"BFni1178_CR39","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux, H. et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737\u2013742 (1997).","journal-title":"Nature"},{"key":"BFni1178_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/intimm\/dxh122","volume":"16","author":"E Nishimura","year":"2004","unstructured":"Nishimura, E. et al. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1189\u20131201 (2004).","journal-title":"Int. Immunol."},{"key":"BFni1178_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","volume":"16","author":"H Yagi","year":"2004","unstructured":"Yagi, H. et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643\u20131656 (2004).","journal-title":"Int. Immunol."},{"key":"BFni1178_CR42","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.4049\/jimmunol.165.6.3105","volume":"165","author":"LA Stephens","year":"2000","unstructured":"Stephens, L.A. & Mason, D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25\u2212 subpopulations. J. Immunol. 165, 3105\u20133110 (2000).","journal-title":"J. Immunol."},{"key":"BFni1178_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ni1180","volume":"6","author":"H von Boehmer","year":"2005","unstructured":"von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338\u2013344 (2005).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon, B. et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431\u2013440 (2000).","journal-title":"Immunity"},{"key":"BFni1178_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295\u2013302 (2000).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303\u2013310 (2000).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR47","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4049\/jimmunol.163.3.1128","volume":"163","author":"MF Bachmann","year":"1999","unstructured":"Bachmann, M.F. et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128\u20131131 (1999).","journal-title":"J. Immunol."},{"key":"BFni1178_CR48","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1002\/eji.200425143","volume":"34","author":"Q Tang","year":"2004","unstructured":"Tang, Q. et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996\u20133005 (2004).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR49","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F","volume":"32","author":"CN Manzotti","year":"2002","unstructured":"Manzotti, C.N. et al. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. 32, 2888\u20132896 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR50","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206\u20131212 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR51","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.4049\/jimmunol.172.7.4100","volume":"172","author":"DH Munn","year":"2004","unstructured":"Munn, D.H., Sharma, M.D. & Mellor, A.L. Ligation of B7\u20131\/B7\u20132 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J. Immunol. 172, 4100\u20134110 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR52","doi-asserted-by":"publisher","first-page":"10398","DOI":"10.1073\/pnas.0403342101","volume":"101","author":"S Paust","year":"2004","unstructured":"Paust, S., Lu, L., McCarty, N. & Cantor, H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101, 10398\u201310403 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR53","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","volume":"171","author":"Q Tang","year":"2003","unstructured":"Tang, Q. et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348\u20133352 (2003).","journal-title":"J. Immunol."},{"key":"BFni1178_CR54","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int. Immunol. 10, 1969\u20131980 (1998).","journal-title":"Int. Immunol."},{"key":"BFni1178_CR55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton, A.M. & Shevach, E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287\u2013296 (1998).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1084\/jem.20030422","volume":"198","author":"S Yamazaki","year":"2003","unstructured":"Yamazaki, S. et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235\u2013247 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR57","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/intimm\/dxh178","volume":"16","author":"Z Fehervari","year":"2004","unstructured":"Fehervari, Z. & Sakaguchi, S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16, 1769\u20131780 (2004).","journal-title":"Int. Immunol."},{"key":"BFni1178_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","volume":"17","author":"AV Collins","year":"2002","unstructured":"Collins, A.V. et al. The interaction properties of costimulatory molecules revisited. Immunity 17, 201\u2013210 (2002).","journal-title":"Immunity"},{"key":"BFni1178_CR59","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.4049\/jimmunol.172.5.2778","volume":"172","author":"Y Zheng","year":"2004","unstructured":"Zheng, Y. et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172, 2778\u20132784 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","volume":"3","author":"J Shimizu","year":"2002","unstructured":"Shimizu, J. et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135\u2013142 (2002).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","volume":"16","author":"RS McHugh","year":"2002","unstructured":"McHugh, R.S. et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311\u2013323 (2002).","journal-title":"Immunity"},{"key":"BFni1178_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1182\/blood-2001-12-0276","volume":"100","author":"S Ronchetti","year":"2002","unstructured":"Ronchetti, S., Nocentini, G., Riccardi, C. & Pandolfi, P.P. Role of GITR in activation response of T lymphocytes. Blood 100, 350\u2013352 (2002).","journal-title":"Blood"},{"key":"BFni1178_CR63","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.4049\/jimmunol.172.12.7306","volume":"172","author":"F Kanamaru","year":"2004","unstructured":"Kanamaru, F. et al. Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells. J. Immunol. 172, 7306\u20137314 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR64","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","volume":"173","author":"GL Stephens","year":"2004","unstructured":"Stephens, G.L. et al. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J. Immunol. 173, 5008\u20135020 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR65","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.4049\/jimmunol.172.10.5823","volume":"172","author":"HB Ji","year":"2004","unstructured":"Ji, H.B. et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172, 5823\u20135827 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR66","doi-asserted-by":"publisher","first-page":"15059","DOI":"10.1073\/pnas.2334901100","volume":"100","author":"M Tone","year":"2003","unstructured":"Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100, 15059\u201315064 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR67","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4049\/jimmunol.166.1.353","volume":"166","author":"A Kumanogoh","year":"2001","unstructured":"Kumanogoh, A. et al. Increased T cell autoreactivity in the absence of CD40\u2013CD40 ligand interactions: a role of CD40 in regulatory T cell development. J. Immunol. 166, 353\u2013360 (2001).","journal-title":"J. Immunol."},{"key":"BFni1178_CR68","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1074-7613(03)00327-3","volume":"19","author":"P Serra","year":"2003","unstructured":"Serra, P. et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19, 877\u2013889 (2003).","journal-title":"Immunity"},{"key":"BFni1178_CR69","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1172\/JCI200420483","volume":"114","author":"H Bour-Jordan","year":"2004","unstructured":"Bour-Jordan, H. et al. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114, 979\u2013987 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFni1178_CR70","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.1078231","volume":"299","author":"C Pasare","year":"2003","unstructured":"Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033\u20131036 (2003).","journal-title":"Science"},{"key":"BFni1178_CR71","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2004.10.006","volume":"21","author":"C Pasare","year":"2004","unstructured":"Pasare, C. & Medzhitov, R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21, 733\u2013741 (2004).","journal-title":"Immunity"},{"key":"BFni1178_CR72","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1084\/jem.20021633","volume":"197","author":"I Caramalho","year":"2003","unstructured":"Caramalho, I. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403\u2013411 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR73","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1084\/jem.194.5.629","volume":"194","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K., Kitani, A. & Strober, W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor \u03b2. J. Exp. Med. 194, 629\u2013644 (2001).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR74","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1073\/pnas.0400810101","volume":"101","author":"Y Peng","year":"2004","unstructured":"Peng, Y. et al. TGF-\u03b2 regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101, 4572\u20134577 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR75","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.4049\/jimmunol.173.11.6526","volume":"173","author":"S Huber","year":"2004","unstructured":"Huber, S. et al. Cutting edge: TGF-\u03b2 signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J. Immunol. 173, 6526\u20136531 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR76","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.coph.2004.05.001","volume":"4","author":"C Thompson","year":"2004","unstructured":"Thompson, C. & Powrie, F. Regulatory T cells. Curr. Opin. Pharmacol. 4, 408\u2013414 (2004).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFni1178_CR77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.immuni.2004.07.009","volume":"21","author":"CS Hsieh","year":"2004","unstructured":"Hsieh, C.S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267\u2013277 (2004).","journal-title":"Immunity"},{"key":"BFni1178_CR78","doi-asserted-by":"publisher","first-page":"15434","DOI":"10.1073\/pnas.0404444101","volume":"101","author":"J Reddy","year":"2004","unstructured":"Reddy, J. et al. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101, 15434\u201315439 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR79","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1073\/pnas.1834479100","volume":"100","author":"H Nishikawa","year":"2003","unstructured":"Nishikawa, H. et al. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci. USA 100, 10902\u201310906 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR80","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1073\/pnas.1533365100","volume":"100","author":"L Klein","year":"2003","unstructured":"Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886\u20138891 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20030315","volume":"198","author":"LS Walker","year":"2003","unstructured":"Walker, L.S. et al. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198, 249\u2013258 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR82","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.20030686","volume":"198","author":"S Fisson","year":"2003","unstructured":"Fisson, S. et al. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198, 737\u2013746 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR83","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1093\/clinids\/7.Supplement_1.S170","volume":"7","author":"F Ginsberg-Fellner","year":"1985","unstructured":"Ginsberg-Fellner, F. et al. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev. Infect. Dis. 7, S170\u2013S176 (1985).","journal-title":"Rev. Infect. Dis."},{"key":"BFni1178_CR84","first-page":"1129","volume":"9","author":"KE Sullivan","year":"2002","unstructured":"Sullivan, K.E., McDonald-McGinn, D. & Zackai, E.H. CD4+ CD25+ T-cell production in healthy humans and in patients with thymic hypoplasia. Clin. Diagn. Lab. Immunol. 9, 1129\u20131131 (2002).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"BFni1178_CR85","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506\u2013511 (2003).","journal-title":"Nature"},{"key":"BFni1178_CR86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/5941","volume":"21","author":"JA Encinas","year":"1999","unstructured":"Encinas, J.A. et al. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat. Genet. 21, 158\u2013160 (1999).","journal-title":"Nat. Genet."},{"key":"BFni1178_CR87","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1006\/cyto.1999.0609","volume":"12","author":"PL Podolin","year":"2000","unstructured":"Podolin, P.L. et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine 12, 477\u2013482 (2000).","journal-title":"Cytokine"},{"key":"BFni1178_CR88","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1084\/jem.20040139","volume":"199","author":"Q Tang","year":"2004","unstructured":"Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455\u20131465 (2004).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR89","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20040180","volume":"199","author":"KV Tarbell","year":"2004","unstructured":"Tarbell, K.V. et al. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467\u20131477 (2004).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR90","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach, J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911\u201320 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFni1178_CR91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","volume":"12","author":"T Boon","year":"1994","unstructured":"Boon, T. et al. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12, 337\u2013365 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni1178_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn, G.P., Old, L.J. & Schreiber, R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137\u2013148 (2004).","journal-title":"Immunity"},{"key":"BFni1178_CR93","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","volume":"163","author":"J Shimizu","year":"1999","unstructured":"Shimizu, J., Yamazaki, S. & Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211\u20135218 (1999).","journal-title":"J. Immunol."},{"key":"BFni1178_CR94","first-page":"3128","volume":"59","author":"S Onizuka","year":"1999","unstructured":"Onizuka, S. et al. Tumor rejection by in vitro administration of anti-CD25 (interleukin-2 receptor \u03b1) monoclonal antibody. Cancer Res. 59, 3128\u20133133 (1999).","journal-title":"Cancer Res."},{"key":"BFni1178_CR95","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller, R.P. et al. J. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823\u2013832 (2001).","journal-title":"J. Exp. Med."},{"key":"BFni1178_CR96","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1002\/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1","volume":"32","author":"D Golgher","year":"2002","unstructured":"Golgher, D. et al. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32, 3267\u20133275 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR97","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.4049\/jimmunol.172.10.5967","volume":"172","author":"NA Danke","year":"2004","unstructured":"Danke, N.A. et al. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967\u20135972 (2004).","journal-title":"J. Immunol."},{"key":"BFni1178_CR98","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1073\/pnas.1533209100","volume":"100","author":"GQ Phan","year":"2003","unstructured":"Phan, G.Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 100, 8372\u20138377 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1178_CR99","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","volume":"104","author":"P Hoffmann","year":"2004","unstructured":"Hoffmann, P. et al. Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells. Blood 104, 895\u2013903 (2004).","journal-title":"Blood"},{"key":"BFni1178_CR100","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2004-01-0151","volume":"104","author":"WR Godfrey","year":"2004","unstructured":"Godfrey, W.R. et al. In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104, 453\u2013461 (2004).","journal-title":"Blood"},{"key":"BFni1178_CR101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1027","volume":"3","author":"KJ Wood","year":"2003","unstructured":"Wood, K.J. & Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199\u2013210 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni1178_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.smim.2003.12.007","volume":"16","author":"H Waldmann","year":"2004","unstructured":"Waldmann, H. et al. Regulatory T cells and organ transplantation. Semin. Immunol. 16, 119\u2013126 (2004).","journal-title":"Semin. Immunol."},{"key":"BFni1178_CR103","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ni1037","volume":"5","author":"VR Aluvihare","year":"2004","unstructured":"Aluvihare, V.R., Kallikourdis, M. & Betz, A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266\u2013271 (2004).","journal-title":"Nat. Immunol."},{"key":"BFni1178_CR104","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985\u2013988 (1995).","journal-title":"Science"},{"key":"BFni1178_CR105","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA T\\ivol","year":"1995","unstructured":"T\\ivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541\u2013547 (1995).","journal-title":"Immunity"},{"key":"BFni1178_CR106","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/eji.1830260730","volume":"26","author":"O Taguchi","year":"1996","unstructured":"Taguchi, O. & Takahashi, T. Administration of anti-interleukin-2 receptor \u03b1 antibody in vivo induces localized autoimmune disease. Eur. J. Immunol. 26, 1608\u20131612 (1996).","journal-title":"Eur. J. Immunol."},{"key":"BFni1178_CR107","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.4049\/jimmunol.168.12.5979","volume":"168","author":"RS McHugh","year":"2002","unstructured":"McHugh, R.S. & Shevach, E.M. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J. Immunol. 168, 5979\u20135983 (2002).","journal-title":"J. Immunol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni1178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1178","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T04:37:41Z","timestamp":1706071061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni1178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,22]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BFni1178"],"URL":"https:\/\/doi.org\/10.1038\/ni1178","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,22]]}}}